Mar 4, 2026 09:25AM
Mar 4, 2026 09:25AM
Feb 5, 2026 09:15AM
Jan 22, 2026 09:22AM
Jan 22, 2026 09:20AM
Jan 12, 2026 09:10AM
Jan 12, 2026 09:10AM Lexaria Releases Annual Letter from the CEO
Dec 30, 2025 09:20AM
Dec 30, 2025 09:20AM
Dec 23, 2025 09:29AM
Dec 23, 2025 09:29AM
Dec 16, 2025 04:00PM
Dec 16, 2025 04:00PM
Dec 15, 2025 08:01AM Lexaria Bioscience raises $3.5 million in registered direct offering
Dec 15, 2025 08:00AM
Nov 12, 2025 09:11AM
Nov 12, 2025 09:10AM
Oct 9, 2025 09:20AM
Oct 9, 2025 09:20AM
Sep 29, 2025 04:30PM
Sep 29, 2025 04:30PM Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Sep 26, 2025 08:00AM
Sep 26, 2025 08:00AM
Sep 19, 2025 11:25AM
Sep 19, 2025 11:20AM
Aug 27, 2025 09:20AM
Aug 14, 2025 09:20AM
Aug 14, 2025 09:20AM Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone
Aug 6, 2025 09:20AM
Jul 28, 2025 09:25AM
Jul 28, 2025 09:25AM
Jul 23, 2025 09:28AM
Jul 23, 2025 09:25AM
Jun 23, 2025 09:15AM
Jun 23, 2025 09:15AM Lexaria Reaches Patent Milestone - 50 Patents Now Granted Worldwide
Jun 11, 2025 09:05AM
Jun 11, 2025 09:05AM
Jun 5, 2025 09:20AM
May 12, 2025 09:02AM
May 12, 2025 09:00AM
Apr 28, 2025 04:15PM
Apr 25, 2025 08:02AM Lexaria Bioscience (LEXX) Prices 2M Share Offering at $1/sh
Apr 25, 2025 08:00AM
Apr 23, 2025 09:10AM
Apr 2, 2025 09:13AM
Apr 2, 2025 09:05AM
Mar 18, 2025 09:16AM
Mar 18, 2025 09:15AM
Feb 27, 2025 08:00AM The Global Revolution in Healthcare Driven by GLP-1 Drugs and the role of Lexaria Bioscience
Feb 24, 2025 08:02AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All